A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

NCT02486406 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: Ombitasvir/paritaprevir/ritonavir
DRUG: Dasabuvir
DRUG: Ribavirin
DRUG: Ombitasvir mini tablet
DRUG: Paritaprevir mini tablet
DRUG: Ritonavir mini tablet
DRUG: Dasabuvir mini tablet
DRUG: Ribavirin solution

Sponsor

AbbVie